Stock ALLK ALLAKOS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Allakos Inc.

Equities

ALLK

US01671P1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.05 USD -0.94% Intraday chart for Allakos Inc. 0.00% -61.54%
Mar. 15 North American Morning Briefing : Inflation Worries Continue to Weigh on Mood DJ
Mar. 14 Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood
DJ
Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Allakos Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
GL
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
AQ
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
GL
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
AQ
Allakos Inc. Announces Publication Highlighting AK006 Mast Cell Inhibition
CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK
PR
North American Morning Briefing : TSMC Results -2-
DJ
Sector Update: Health Care Stocks Slipping Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Allakos Shares Fall After Downgrades by Jefferies, Cantor Fitzgerald, Lifesci Capital
MT
JMP Securities Adjusts Allakos' Price Target to $3 From $10, Maintains Market Outperform Rating
MT
Barclays Trims Allakos' Price Target to $1 From $1.50, Maintains Underweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALLK Stock
  4. News Allakos Inc.